Theresa Ryan

1.5k total citations
26 papers, 929 citations indexed

About

Theresa Ryan is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Hematology. According to data from OpenAlex, Theresa Ryan has authored 26 papers receiving a total of 929 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Public Health, Environmental and Occupational Health and 5 papers in Hematology. Recurrent topics in Theresa Ryan's work include Acute Lymphoblastic Leukemia research (6 papers), Alzheimer's disease research and treatments (5 papers) and Colorectal Cancer Treatments and Studies (5 papers). Theresa Ryan is often cited by papers focused on Acute Lymphoblastic Leukemia research (6 papers), Alzheimer's disease research and treatments (5 papers) and Colorectal Cancer Treatments and Studies (5 papers). Theresa Ryan collaborates with scholars based in United States, Canada and Australia. Theresa Ryan's co-authors include David T. Teachey, Stephan A. Grupp, Howard S. Höchster, Junior Hall, Thomas M. Habermann, Natalia Colocci, Stanley Frankel, Leo I. Gordon, Edie Weller and Randy D. Gascoyne and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Theresa Ryan

26 papers receiving 912 citations

Peers

Countries citing papers authored by Theresa Ryan

Since Specialization

Citations

This map shows the geographic impact of Theresa Ryan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Theresa Ryan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Theresa Ryan more than expected).

Fields of papers citing papers by Theresa Ryan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Theresa Ryan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Theresa Ryan. The network helps show where Theresa Ryan may publish in the future.

Co-authorship network of co-authors of Theresa Ryan

This figure shows the co-authorship network connecting the top 25 collaborators of Theresa Ryan. A scholar is included among the top collaborators of Theresa Ryan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Theresa Ryan. Theresa Ryan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Inhibition of the Sec61 translocon overcomes cytokine‐induced glucocorticoid resistance in T‐cell acute lymphoblastic leukaemia 2022 ·British Journal of Haematology ·Lauren K. Meyer, Cristina Delgado-Martín, Phillip P. Sharp, Benjamin J. Huang, (unknown), Tiffaney L. Vincent, Theresa Ryan, Terzah M. Horton, Brent L. Wood, David T. Teachey, Jack Taunton, Christopher J. Kirk, Michelle L. Hermiston	6
2	Docetaxel, Oxaliplatin, and 5-Fluorouracil (DOF) in Metastatic and Unresectable Gastric/Gastroesophageal Junction Adenocarcinoma: A Phase II Study with Long-Term Follow-Up 2019 ·The Oncologist ·Ari J. Rosenberg, Alfred Rademaker, Howard S. Höchster, Theresa Ryan, Thomas A. Hensing, Veena Shankaran, (unknown), Devalingam Mahalingam, Mary F. Mulcahy, Al B. Benson	14
3	Can we downstage locally advanced pancreatic cancer to resectable? A phase I/II study of induction oxaliplatin and 5-FU chemoradiation 2018 ·Journal of Gastrointestinal Oncology ·(unknown), (unknown), Marcovalerio Melis, Theresa Ryan, Howard S. Höchster, Deirdre Jill Cohen, Anurag Chandra, H. Leon Pachter, Elliot Newman	3
4	Potent efficacy of combined PI3K/mTOR and JAK or ABL inhibition in murine xenograft models of Ph-like acute lymphoblastic leukemia 2016 ·Blood ·Sarah K. Tasian, David T. Teachey, Yong Li, Feng Shen, Richard C. Harvey, I‐Ming Chen, Theresa Ryan, Tiffaney L. Vincent, Cheryl L. Willman, Alexander E. Perl, Stephen P. Hunger, Mignon L. Loh, Martin Carroll, Stephan A. Grupp	110
5	Potent Efficacy of Combined PI3K/mTOR and JAK or SRC/ABL Inhibition in Philadelphia Chromosome-like Acute Lymphoblastic Leukemia 2015 ·Blood ·Sarah K. Tasian, Yong Li, Feng Shen, Theresa Ryan, Tiffaney L. Vincent, David T. Teachey, Shannon L. Maude, Richard C. Harvey, I-Ming L. Chen, Cheryl L. Willman, Alexander E. Perl, Stephen P. Hunger, Mignon L. Loh, Martin Carroll, Stephan A. Grupp	2
6	Efficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia 2015 ·Blood ·Shannon L. Maude, Sibasish Dolai, Cristina Delgado-Martín, Tiffaney L. Vincent, Alissa K. Robbins, Arthavan Selvanathan, Theresa Ryan, Junior Hall, Andrew Wood, Sarah K. Tasian, Stephen P. Hunger, Mignon L. Loh, Charles G. Mullighan, Brent L. Wood, Michelle L. Hermiston, Stephan A. Grupp, Richard B. Lock, David T. Teachey	158
7	Phase 1/2 study of KRN330, a fully human anti-A33 monoclonal antibody, plus irinotecan as second-line treatment for patients with metastatic colorectal cancer 2014 ·Investigational New Drugs ·Johanna C. Bendell, Heinz‐Josef Lenz, Theresa Ryan, Bassel F. El‐Rayes, John L. Marshall, Manuel Modiano, Lowell L. Hart, (unknown), Thomas J. George, Daisuke Nakashima, Jordan Berlin	8
8	In Vivo Efficacy of PI3K Pathway Signaling Inhibition for Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia 2013 ·Blood ·Sarah K. Tasian, Yong Li, Theresa Ryan, Tiffaney L. Vincent, David T. Teachey, Mignon L. Loh, Stephen P. Hunger, Martin Carroll, Stephan A. Grupp	5
9	Randomized phase 2 study of pegylated SN‐38 (EZN‐2208) or irinotecan plus cetuximab in patients with advanced colorectal cancer 2013 ·Cancer ·Christopher R. Garrett, Tanios Bekaii‐Saab, Theresa Ryan, George A. Fisher, Sally Clive, Petr Kavan, Einat Shacham‐Shmueli, Aby Buchbinder, Richard M. Goldberg	45
10	Postoperative Intraperitoneal 5-Fluoro-2′-Deoxyuridine Added to Chemoradiation in Patients Curatively Resected (R0) for Locally Advanced Gastric and Gastroesophageal Junction Adenocarcinoma 2011 ·Annals of Surgical Oncology ·Deirdre Jill Cohen, Elliot Newman, Syma Iqbal, (unknown), M Potmĕsil, Theresa Ryan, Bernadine R. Donahue, Anurag Chandra, Mengling Liu, (unknown), Spiros Hiotis, Leon H. Pachter, Howard S. Höchster, Franco M. Muggia	3
11	Phase II study of darinaparsin in patients with advanced hepatocellular carcinoma 2009 ·Investigational New Drugs ·Jennifer Wu, Charles Henderson, Lynn G. Feun, Peter J. Van Veldhuizen, Philip J. Gold, Hui Zheng, Theresa Ryan, Lawrence S. Blaszkowsky, Haobin Chen, Max Costa, Barry P. Rosenzweig, (unknown), Howard S. Höchster, Franco M. Muggia, Giovanni Abbadessa, Jonathan J. Lewis, Andrew X. Zhu	33
12	Phase I/II Trial of Induction Chemotherapy Followed by Concurrent Chemoradiotherapy and Surgery for Locoregionally Advanced Pancreatic Cancer 2008 ·Annals of Surgical Oncology ·Jennifer L. Marti, Howard S. Höchster, Spiros Hiotis, Bernadine Donahue, Theresa Ryan, Elliot Newman	31
13	mTOR inhibitors are synergistic with methotrexate: an effective combination to treat acute lymphoblastic leukemia 2008 ·Blood ·David T. Teachey, Cecilia Sheen, Junior Hall, Theresa Ryan, Valerie I. Brown, Jonathan D. Fish, Gregor S. D. Reid, Alix E. Seif, Robin E. Norris, Yueh J. Chang, Martin Carroll, Stephan A. Grupp	91
14	Targeting Notch Signaling as a Safe and Effective Treatment for Autoimmune and Lymphoproliferative Diseases. 2006 ·Blood ·David T. Teachey, Alix E. Seif, Junior Hall, Theresa Ryan, Gregor S. D. Reid, Yueh J. Chang, Valerie I. Brown, Stephan A. Grupp	1
15	A Pilot Study of Prednisone in Alzheimer's Disease 1996 ·Dementia and Geriatric Cognitive Disorders ·Paul Aisen, Deborah B. Marin, Larry D. Altstiel, (unknown), (unknown), (unknown), Theresa Ryan, Kenneth L. Davis	36
16	l-Deprenyl and physostigmine for the treatment of Alzheimer's disease 1995 ·Psychiatry Research ·Deborah B. Marin, Linda M. Bierer, Brian Lawlor, Theresa Ryan, (unknown), James Schmeidler, Richard C. Mohs, Kenneth L. Davis	32
17	Plasma 3-methoxy-4-hydroxyphenylglycol (MHPG) and clinical symptoms in Alzheimer's disease 1995 ·Biological Psychiatry ·Brian Lawlor, Linda M. Bierer, Theresa Ryan, James Schmeidler, Peter J. Knott, (unknown), Richard C. Mohs, Kenneth L. Davis	29
18	A Pilot Study of Oral Physostigmine Plus Yohimbine in Patients with Alzheimer Disease 1993 ·Alzheimer Disease & Associated Disorders ·Linda M. Bierer, Paul Aisen, Michael Davidson, Theresa Ryan, Robert G. Stern, James Schmeidler, Kenneth L. Davis	14
19	CSF Somatostatin in alzheimer's disease, depressed patients, and control subjects 1988 ·Biological Psychiatry ·Kenneth L. Davis, Michael Davidson, Ren-Kui Yang, Bonnie M. Davis, Larry J. Siever, Richard C. Mohs, Theresa Ryan, (unknown), Linda M. Bierer, Steven D. Targum	32
20	Effect of apomorphine infusion on plasma homovanillic acid in normal subjects 1986 ·Journal of Psychiatric Research ·Michael Davidson, Kenneth S. Kendler, Richard C. Mohs, Eric Hollander, Theresa Ryan, Kenneth L. Davis	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact